• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interference of direct oral anticoagulants in haemostasis assays: high potential for diagnostic false positives and false negatives.

作者信息

Favaloro Emmanuel J, Lippi Giuseppe

机构信息

Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Sydney Centres for Thrombosis and Haemostasis, NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia.

Section of Clinical Biochemistry, University of Verona, Verona, Italy.

出版信息

Blood Transfus. 2017 Oct;15(6):491-494. doi: 10.2450/2017.0301-16. Epub 2017 Mar 7.

DOI:10.2450/2017.0301-16
PMID:28287385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5649956/
Abstract
摘要

相似文献

1
Interference of direct oral anticoagulants in haemostasis assays: high potential for diagnostic false positives and false negatives.直接口服抗凝剂对止血检测的干扰：诊断出现假阳性和假阴性的可能性很大。
Blood Transfus. 2017 Oct;15(6):491-494. doi: 10.2450/2017.0301-16. Epub 2017 Mar 7.
2
Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.狼疮抗凝物（LA）在服用直接口服抗凝剂（DOACs）患者中的实验室检测：潜在的假阳性和假阴性。
Pathology. 2019 Apr;51(3):292-300. doi: 10.1016/j.pathol.2018.11.008. Epub 2019 Jan 18.
3
A method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays: a statistical terminology.一种在RNA干扰高通量筛选试验中用于命中选择的对假阴性和假阳性进行灵活且平衡控制的方法：一种统计术语。
J Biomol Screen. 2008 Apr;13(4):309-11. doi: 10.1177/1087057108316314.
4
An effective method for controlling false discovery and false nondiscovery rates in genome-scale RNAi screens.一种在全基因组RNA干扰筛选中控制错误发现率和错误未发现率的有效方法。
J Biomol Screen. 2010 Oct;15(9):1116-22. doi: 10.1177/1087057110381783. Epub 2010 Sep 20.
5
Trade-off between false positives and false negatives in the linkage analysis of complex traits.复杂性状连锁分析中假阳性与假阴性之间的权衡
Genet Epidemiol. 1997;14(5):453-64. doi: 10.1002/(SICI)1098-2272(1997)14:5<453::AID-GEPI1>3.0.CO;2-2.
6
Estimating false positives and negatives in brain networks.估计脑网络中的假阳性和假阴性。
Neuroimage. 2013 Apr 15;70:402-9. doi: 10.1016/j.neuroimage.2012.12.066. Epub 2013 Jan 5.
7
A closer look at self-reported suicide attempts: false positives and false negatives.进一步观察自我报告的自杀尝试：假阳性和假阴性。
Suicide Life Threat Behav. 2011 Feb;41(1):1-5. doi: 10.1111/j.1943-278X.2010.00005.x. Epub 2011 Jan 24.
8
Handling false negatives, false positives and reporting limits in analytical proficiency tests.分析能力验证试验中假阴性、假阳性及报告限的处理
Analyst. 1997 May;122(5):495-7. doi: 10.1039/a701411b.
9
The histopathologic misdiagnosis of melanoma: sources and consequences of "false positives" and "false negatives".黑色素瘤的组织病理学误诊：“假阳性”和“假阴性”的来源及后果
J Am Acad Dermatol. 2000 Oct;43(4):704-6. doi: 10.1067/mjd.2000.109275d.
10
Day 4 is better than day 3 for a single patch test reading.对于单次斑贴试验读数而言，第4天比第3天更好。
Contact Dermatitis. 1996 Jun;34(6):402-4. doi: 10.1111/j.1600-0536.1996.tb02241.x.

引用本文的文献

1
Oral Anticoagulation Therapy: An Update on Usage and Costs in the Endemic COVID-19 Era.口服抗凝治疗：新冠疫情流行时代的使用情况与成本最新进展
J Clin Med. 2025 Apr 9;14(8):2591. doi: 10.3390/jcm14082591.
2
Protein S contributes to the paradoxical increase in thrombin generation by low-dose dabigatran in the presence of thrombomodulin.在存在血栓调节蛋白的情况下，蛋白S导致低剂量达比加群引起的凝血酶生成出现反常增加。
Blood Coagul Fibrinolysis. 2024 Oct 1;35(7):334-339. doi: 10.1097/MBC.0000000000001320. Epub 2024 Aug 22.
3
Post-analytical Issues in Hemostasis and Thrombosis Testing: An Update.止血和血栓形成检测的分析后问题：更新。
Methods Mol Biol. 2023;2663:787-811. doi: 10.1007/978-1-0716-3175-1_53.
4
Laboratory Testing for Activated Protein C Resistance (APCR): An Update.活化蛋白 C 抵抗（APCR）的实验室检测：更新。
Methods Mol Biol. 2023;2663:203-210. doi: 10.1007/978-1-0716-3175-1_11.
5
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients.狼疮抗凝物阳性患者中达比加群、利伐沙班和阿哌沙班测定的评估
Diagnostics (Basel). 2021 Nov 2;11(11):2027. doi: 10.3390/diagnostics11112027.
6
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.2021年欧洲心律协会心房颤动患者使用非维生素K拮抗剂口服抗凝药实用指南。
Europace. 2021 Oct 9;23(10):1612-1676. doi: 10.1093/europace/euab065.
7
Management of an acute cerebral embolic infarct with thrombolysis and mechanical thrombectomy in the presence of an aortic arch floating thrombus.在存在主动脉弓漂浮血栓的情况下，采用溶栓和机械取栓治疗急性脑栓塞性梗死
BMJ Case Rep. 2021 Apr 20;14(4):e238707. doi: 10.1136/bcr-2020-238707.
8
Hypercoagulable workup in a community hospital setting: to test or not to test; that is the question.社区医院环境下的高凝检查：做检查还是不做检查；这是个问题。
J Community Hosp Intern Med Perspect. 2019 Nov 1;9(5):392-396. doi: 10.1080/20009666.2019.1655627. eCollection 2019.
9
Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes.房颤消融当日行最小中断与不中断直接口服抗凝治疗时的激活凝血时间：序贯变化、直接口服抗凝剂之间的差异，以及消融安全性结局。
J Cardiovasc Electrophysiol. 2019 Dec;30(12):2823-2833. doi: 10.1111/jce.14260. Epub 2019 Nov 12.
10
Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the Residual Activity of Dabigatran, Rivaroxaban, and Apixaban.通过 LC-MS/MS 测定达比加群、利伐沙班和阿哌沙班的残留活性的 DOAC-Stop 程序评估。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619872556. doi: 10.1177/1076029619872556.

本文引用的文献

1
Thrombophilia testing in patients taking direct oral anticoagulants. Handle with care.正在服用直接口服抗凝剂的患者的血栓形成倾向检测。小心处理。
Diagnosis (Berl). 2014 Dec 1;1(4):311-312. doi: 10.1515/dx-2014-0054.
2
Effect of dabigatran on a prothrombinase-based assay for detecting activated protein C resistance: an ex vivo and in vitro study in normal subjects and factor V Leiden carriers.达比加群对基于凝血酶原酶的检测活化蛋白 C 抵抗的影响：正常受试者和因子 V Leiden 携带者的离体和体外研究。
Blood Transfus. 2017 Oct;15(6):562-567. doi: 10.2450/2017.0199-16. Epub 2017 Mar 7.
3
The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.直接Xa因子抑制剂阿哌沙班和利伐沙班对止血试验的影响：使用体外和体内样本的综合评估
Pathology. 2016 Jan;48(1):60-71. doi: 10.1016/j.pathol.2015.11.025. Epub 2015 Dec 17.
4
The effect of dabigatran on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.达比加群对止血检测的影响：使用体外和离体样本的综合评估。
Pathology. 2015 Jun;47(4):355-64. doi: 10.1097/PAT.0000000000000252.
5
Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients' preference.根据患者的偏好确定使用两种口服抗凝剂之一继续进行抗凝治疗的建议。
Semin Thromb Hemost. 2015 Mar;41(2):166-77. doi: 10.1055/s-0035-1546467. Epub 2015 Feb 19.
6
Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors.直接口服抗凝剂或非维生素K拮抗剂口服抗凝剂时代的实验室检测：测量其活性及避免诊断错误的实用指南
Semin Thromb Hemost. 2015 Mar;41(2):208-27. doi: 10.1055/s-0035-1546827. Epub 2015 Feb 19.
7
The new or non-vitamin K antagonist oral anticoagulants: what have we learned since their debut.新型或非维生素K拮抗剂口服抗凝药：自首次亮相以来我们学到了什么。
Semin Thromb Hemost. 2015 Mar;41(2):188-94. doi: 10.1055/s-0035-1544159. Epub 2015 Feb 15.
8
Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus?直接口服抗凝剂（DOACs）实验室评估的最新指南与建议：是否存在共识？
Clin Chem Lab Med. 2015 Feb;53(2):185-97. doi: 10.1515/cclm-2014-0767.
9
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.新型口服抗凝剂与华法林治疗心房颤动患者的疗效和安全性比较：随机试验的荟萃分析。
Lancet. 2014 Mar 15;383(9921):955-62. doi: 10.1016/S0140-6736(13)62343-0. Epub 2013 Dec 4.
10
The futility of thrombophilia testing.血栓形成倾向检测的无用性。
Clin Chem Lab Med. 2014 Apr;52(4):499-503. doi: 10.1515/cclm-2013-0560.